Clinical Trial Update: Meropenem vs Cefotaxime as Empirical Treatment of SBP [Phase 4]

View source ↗

Summary

Phase 4 trial comparing meropenem to cefotaxime as empirical therapy for spontaneous bacterial peritonitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Cefotaxime (Cefotaxime)
• Meropenem (Meropenem)

Snippet

Sponsor: Assiut University | Conditions: Spontaneous Bacterial Peritonitis | Phase 4 | Status: UNKNOWN